About the company
Femasys Inc, a pioneering biomedical company, is at the forefront of revolutionizing women's healthcare. With a strong commitment to improving the lives of women around the world, Femasys is dedicated to developing innovative solutions and advancements to address severely underserved areas of healthcare. At the heart of Femasys's mission is the desire to provide women with minimally invasive, non-surgical product technologies that can be easily accessed in the office setting. By offering these innovative solutions, Femasys aims to enhance patient care, improve overall health economics, and empower women to take control of their own health. One of the key focus areas for Femasys is the development of solutions for conditions that have traditionally been underserved or overlooked. Oftentimes, women's healthcare needs are not given the attention and research they deserve, leading to limited treatment options and unaddressed concerns. Femasys recognizes this imbalance and is determined to bridge the gap by introducing effective and accessible solutions. In pursuit of its mission, Femasys collaborates with leading researchers, physicians, and healthcare providers who share the same passion for transforming women's healthcare. By harnessing the combined expertise of these individuals, Femasys is able to drive innovation and bring transformative products to market. One of the notable advancements made by Femasys is the development of its flagship product, the FemVue® Saline-Air Device. This groundbreaking technology offers a non-surgical and minimally invasive approach for evaluating a woman's fallopian tubes. Traditionally, this evaluation has required more invasive procedures such as hysterosalpingography (HSG) or laparoscopy. However, with FemVue®, physicians can now perform a simple saline-air trial in the office, enabling a quicker, more comfortable, and cost-effective evaluation for women seeking to understand their fertility options. In addition to the FemVue® Saline-Air Device, Femasys has also developed the FemaSeed™ Intrauterine Device (IUD) Placement Catheter. This innovative catheter simplifies the procedure for IUD placement, making it more accessible in the office setting. By streamlining the process, Femasys aims to increase the availability and utilization of this highly effective contraception method. The impact of Femasys's advancements in women's healthcare extends beyond the clinical setting. By providing non-surgical options that can be conducted in the office, Femasys is eliminating the barriers that have traditionally prevented women from seeking necessary care. With greater accessibility and convenience, women are more likely to prioritize their health and well-being, leading to improved outcomes and overall healthcare economics. Femasys's commitment to transforming women's healthcare goes beyond product development. The company actively engages with patients and healthcare professionals to understand their needs and challenges. By listening to the voices of those directly affected by the limitations in women's healthcare, Femasys strives to continuously innovate and develop solutions that address these unmet needs. In conclusion, Femasys Inc is a biomedical company dedicated to revolutionizing women's healthcare. Through its innovative products and advancements, Femasys aims to provide women with minimally invasive, non-surgical options that are accessible in the office setting. By addressing severely underserved areas of healthcare, Femasys is empowering women, improving patient care, and positively impacting overall health economics.
Website: https://femasys.com
Data updated: June 2, 2026
